Global Transdermal Patch Market Growth 2025-2031

Publication ID:

LPI03256141

Publication Date:

March 26, 2025

Pages:

141

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Transdermal Patch market size is predicted to grow from US$ 7359 million in 2025 to US$ 9170 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
The 鈥淭ransdermal Patch Industry Forecast鈥� looks at past sales and reviews total world Transdermal Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Transdermal Patch sales for 2025 through 2031. With Transdermal Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transdermal Patch industry.
This Insight Report provides a comprehensive analysis of the global Transdermal Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transdermal Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Transdermal Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transdermal Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transdermal Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segmentation by Application:
Rx Channel
OTC Channel
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
骋谤眉苍别苍迟丑补濒
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy鈥檚 Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Transdermal Patch market?
What factors are driving Transdermal Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transdermal Patch market opportunities vary by end market size?
How does Transdermal Patch break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Patch Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Transdermal Patch by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Transdermal Patch by Country/Region, 2020, 2024 & 2031
2.2 Transdermal Patch Segment by Type
2.2.1 Methyl Salicylate-based Patch
2.2.2 Rivastigmine Transdermal Patch
2.2.3 Fentanyl Transdermal Patch
2.2.4 Lidocaine Patch
2.2.5 Diclofenac Patch
2.2.6 Nicotine Transdermal Patch
2.2.7 Others
2.3 Transdermal Patch Sales by Type
2.3.1 Global Transdermal Patch Sales Market Share by Type (2020-2025)
2.3.2 Global Transdermal Patch Revenue and Market Share by Type (2020-2025)
2.3.3 Global Transdermal Patch Sale Price by Type (2020-2025)
2.4 Transdermal Patch Segment by Application
2.4.1 Rx Channel
2.4.2 OTC Channel
2.5 Transdermal Patch Sales by Application
2.5.1 Global Transdermal Patch Sale Market Share by Application (2020-2025)
2.5.2 Global Transdermal Patch Revenue and Market Share by Application (2020-2025)
2.5.3 Global Transdermal Patch Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Transdermal Patch Breakdown Data by Company
3.1.1 Global Transdermal Patch Annual Sales by Company (2020-2025)
3.1.2 Global Transdermal Patch Sales Market Share by Company (2020-2025)
3.2 Global Transdermal Patch Annual Revenue by Company (2020-2025)
3.2.1 Global Transdermal Patch Revenue by Company (2020-2025)
3.2.2 Global Transdermal Patch Revenue Market Share by Company (2020-2025)
3.3 Global Transdermal Patch Sale Price by Company
3.4 Key Manufacturers Transdermal Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transdermal Patch Product Location Distribution
3.4.2 Players Transdermal Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Transdermal Patch by Geographic Region
4.1 World Historic Transdermal Patch Market Size by Geographic Region (2020-2025)
4.1.1 Global Transdermal Patch Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Transdermal Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Transdermal Patch Market Size by Country/Region (2020-2025)
4.2.1 Global Transdermal Patch Annual Sales by Country/Region (2020-2025)
4.2.2 Global Transdermal Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transdermal Patch Sales Growth
4.4 APAC Transdermal Patch Sales Growth
4.5 Europe Transdermal Patch Sales Growth
4.6 Middle East & Africa Transdermal Patch Sales Growth
5 Americas
5.1 Americas Transdermal Patch Sales by Country
5.1.1 Americas Transdermal Patch Sales by Country (2020-2025)
5.1.2 Americas Transdermal Patch Revenue by Country (2020-2025)
5.2 Americas Transdermal Patch Sales by Type (2020-2025)
5.3 Americas Transdermal Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Patch Sales by Region
6.1.1 APAC Transdermal Patch Sales by Region (2020-2025)
6.1.2 APAC Transdermal Patch Revenue by Region (2020-2025)
6.2 APAC Transdermal Patch Sales by Type (2020-2025)
6.3 APAC Transdermal Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transdermal Patch by Country
7.1.1 Europe Transdermal Patch Sales by Country (2020-2025)
7.1.2 Europe Transdermal Patch Revenue by Country (2020-2025)
7.2 Europe Transdermal Patch Sales by Type (2020-2025)
7.3 Europe Transdermal Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Patch by Country
8.1.1 Middle East & Africa Transdermal Patch Sales by Country (2020-2025)
8.1.2 Middle East & Africa Transdermal Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Transdermal Patch Sales by Type (2020-2025)
8.3 Middle East & Africa Transdermal Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Patch
10.3 Manufacturing Process Analysis of Transdermal Patch
10.4 Industry Chain Structure of Transdermal Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transdermal Patch Distributors
11.3 Transdermal Patch Customer
12 World Forecast Review for Transdermal Patch by Geographic Region
12.1 Global Transdermal Patch Market Size Forecast by Region
12.1.1 Global Transdermal Patch Forecast by Region (2026-2031)
12.1.2 Global Transdermal Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Transdermal Patch Forecast by Type (2026-2031)
12.7 Global Transdermal Patch Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Hisamitsu Pharmaceutical
13.1.1 Hisamitsu Pharmaceutical Company Information
13.1.2 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolios and Specifications
13.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hisamitsu Pharmaceutical Main Business Overview
13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Transdermal Patch Product Portfolios and Specifications
13.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Transdermal Patch Product Portfolios and Specifications
13.3.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 UCB Pharma
13.4.1 UCB Pharma Company Information
13.4.2 UCB Pharma Transdermal Patch Product Portfolios and Specifications
13.4.3 UCB Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 UCB Pharma Main Business Overview
13.4.5 UCB Pharma Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Transdermal Patch Product Portfolios and Specifications
13.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Transdermal Patch Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Nitto Denko
13.7.1 Nitto Denko Company Information
13.7.2 Nitto Denko Transdermal Patch Product Portfolios and Specifications
13.7.3 Nitto Denko Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nitto Denko Main Business Overview
13.7.5 Nitto Denko Latest Developments
13.8 骋谤眉苍别苍迟丑补濒
13.8.1 骋谤眉苍别苍迟丑补濒 Company Information
13.8.2 骋谤眉苍别苍迟丑补濒 Transdermal Patch Product Portfolios and Specifications
13.8.3 骋谤眉苍别苍迟丑补濒 Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 骋谤眉苍别苍迟丑补濒 Main Business Overview
13.8.5 骋谤眉苍别苍迟丑补濒 Latest Developments
13.9 IBSA Group
13.9.1 IBSA Group Company Information
13.9.2 IBSA Group Transdermal Patch Product Portfolios and Specifications
13.9.3 IBSA Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 IBSA Group Main Business Overview
13.9.5 IBSA Group Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK Transdermal Patch Product Portfolios and Specifications
13.10.3 GSK Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Luye Pharma Group
13.11.1 Luye Pharma Group Company Information
13.11.2 Luye Pharma Group Transdermal Patch Product Portfolios and Specifications
13.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Luye Pharma Group Main Business Overview
13.11.5 Luye Pharma Group Latest Developments
13.12 Pfizer
13.12.1 Pfizer Company Information
13.12.2 Pfizer Transdermal Patch Product Portfolios and Specifications
13.12.3 Pfizer Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Pfizer Main Business Overview
13.12.5 Pfizer Latest Developments
13.13 Chattem
13.13.1 Chattem Company Information
13.13.2 Chattem Transdermal Patch Product Portfolios and Specifications
13.13.3 Chattem Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Chattem Main Business Overview
13.13.5 Chattem Latest Developments
13.14 Dr Reddy鈥檚 Laboratories
13.14.1 Dr Reddy鈥檚 Laboratories Company Information
13.14.2 Dr Reddy鈥檚 Laboratories Transdermal Patch Product Portfolios and Specifications
13.14.3 Dr Reddy鈥檚 Laboratories Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Dr Reddy鈥檚 Laboratories Main Business Overview
13.14.5 Dr Reddy鈥檚 Laboratories Latest Developments
13.15 Bayer
13.15.1 Bayer Company Information
13.15.2 Bayer Transdermal Patch Product Portfolios and Specifications
13.15.3 Bayer Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Bayer Main Business Overview
13.15.5 Bayer Latest Developments
13.16 Mundipharma
13.16.1 Mundipharma Company Information
13.16.2 Mundipharma Transdermal Patch Product Portfolios and Specifications
13.16.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Mundipharma Main Business Overview
13.16.5 Mundipharma Latest Developments
13.17 Endo International
13.17.1 Endo International Company Information
13.17.2 Endo International Transdermal Patch Product Portfolios and Specifications
13.17.3 Endo International Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Endo International Main Business Overview
13.17.5 Endo International Latest Developments
13.18 Beijing Tide Pharmaceutical
13.18.1 Beijing Tide Pharmaceutical Company Information
13.18.2 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolios and Specifications
13.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Beijing Tide Pharmaceutical Main Business Overview
13.18.5 Beijing Tide Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂